Eric Senneville

30PUBLICATIONS
57CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Orthodontics and dentofacial orthopaedicsMedical microbiology not elsewhere classifiedOral implantology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Nov 01, 2026
Responsible use of new antibiotics for critically ill patients suffering from infections due to carbapenem-resistant organisms-a narrative review for an enablement strategy.

|Apr 16, 2026
Geographical Differences in the Epidemiology and Treatment of Candida Prosthetic Joint Infections.

|Feb 13, 2026
Real-world drug monitoring of dalbavancin using a three-dose regimen of 1500 mg at days 1, 15 and 43 in bone and joint or cardiovascular infection.

Thomas Lin, Eric Senneville, Benjamin Hennart

|Apr 29, 2025
Real-Life Cefiderocol Use in Bone and Joint Infection: A French National Cohort.

Ava Diarra, Maxime Degrendel, Isabelle Eberl

|Mar 17, 2025
Not All in Vein: Oral Antibiotics for Diabetic Foot Osteomyelitis: A Narrative Review.

Benoit Gachet, Marcos C Schechter, David G Armstrong

|Jan 08, 2025
National Cohort of Compassionate Use of Meropenem-Vaborbactam: No Benefit over Meropenem for Pseudomonas aeruginosa.

Aurélien Dinh, Alexandre Bleibtreu, Clara Duran

Pageof 5

Frequent Collaborators

5 joint publications

Jaap J van Netten

4 joint publications

Sicco A Bus

4 joint publications

Matilde Monteiro-Soares

4 joint publications

Olivier Robineau